Eliaz Therapeutics Inc. is raising up to $3M on Dealmaker Securities LLC in class b common stock at $5.56 each; in its filing revenue was $332K and it had 2 employees (Form C-U, 2026-07-07).
Eliaz Therapeutics Inc. filed a Regulation Crowdfunding offering with the SEC through Dealmaker Securities LLC, with a target of $10K and a maximum of $3M. As of November 6, 2026, the offering is open, with a deadline of April 15, 2027. The company gives its address as Santa Rosa, CA (Form C, June 10, 2026).
Sell to companies like Eliaz Therapeutics Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · What it is: Progress update · C-U
- · Intermediary: Dealmaker Securities LLC · Target: $10K · Maximum: $3M · Deadline: 2027-04-15 · Security: Class B Common Stock · C
- · What it is: Progress update · C-U
- · What it is: Annual report · C-AR
- · Intermediary: StartEngine Primary, LLC · Target: $20K · Maximum: $2.49M · Deadline: 2026-04-30 · Security: Class B Common Stock · C/A
Eliaz Therapeutics Inc., based in Santa Rosa, CA, filed 10 Regulation Crowdfunding offering filings with the SEC, the latest on 2026-06-10, raising through Dealmaker Securities LLC. It set a target of $10K and will accept up to $3M. The security offered is class b common stock at $5.56 each. As of its filings the offering is open, with a deadline of 2027-04-15. 14 filings in this family are on record for the company.
Terms at a glance
| Target | $10K |
| Maximum it will accept | $3M |
| Security | Class B Common Stock |
| Price per unit | $5.56 |
| Units at the target | 1,747 |
| Raise above the target | accepted, other |
| Deadline | 2027-04-15 |
| Raising through | Dealmaker Securities LLC |
| What the portal is paid, as filed | The Issuer will pay DealMaker Securities LLC an 8.5% cash commission fee based on the dollar amount of the Securities sold in the Offering. There is also a one-time $38,000 fee and a $15,000 monthly fee payable to DealMaker Securities LLC or its affiliates |
Check before you invest in Eliaz Therapeutics Inc.: who signed the filing and its own figures, free.
Free to see. No signup.
Want the whole picture on Eliaz Therapeutics Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Eliaz Therapeutics Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Eliaz Therapeutics Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
15 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
The filing does not state a company valuation or a minimum investment; the offering page on Dealmaker Securities LLC shows those. Check both before you invest.
Money raised before
Earlier raises by this company that are on file, with the amounts as filed. A figure for a raise is what the company reported, not a check of what it received.
| Filed | What | Amount as filed | Filing |
|---|---|---|---|
| 2025-12-08 | Crowdfunding offering (Form C) | $20K to $2.49M | filing |
| 2024-11-07 | Crowdfunding offering (Form C) | $50K to $1.24M | filing |
| 2025-10-24 | Private placement (Form D) | $850K sold of $850K offered | filing |
Offering filings
| Filed | Intermediary | Target | Maximum | Deadline | Security | Filing |
|---|---|---|---|---|---|---|
| 2026-06-10 | Dealmaker Securities LLC | $10K | $3M | 2027-04-15 | Class B Common Stock | C |
| 2026-03-03 | StartEngine Primary, LLC | $20K | $2.49M | 2026-04-30 | Class B Common Stock | C/A |
| 2025-12-08 | StartEngine Primary, LLC | $20K | $2.49M | 2026-03-09 | Class B Common Stock | C |
| 2025-08-07 | Wefunder Portal LLC | $50K | $3M | 2026-04-30 | Simple Agreement for Future Equity (SAFE) | C/A |
| 2025-07-22 | Wefunder Portal LLC | $50K | $3M | 2026-04-30 | Simple Agreement for Future Equity (SAFE) | C/A |
| 2025-06-13 | Wefunder Portal LLC | $50K | $3M | 2026-04-30 | Simple Agreement for Future Equity (SAFE) | C/A |
| 2025-04-25 | Wefunder Portal LLC | $50K | $1.24M | 2026-04-30 | Simple Agreement for Future Equity (SAFE) | C/A |
| 2025-03-31 | Wefunder Portal LLC | $50K | $1.24M | 2025-04-30 | Simple Agreement for Future Equity (SAFE) | C/A |
| 2025-03-25 | Wefunder Portal LLC | $50K | $1.24M | 2025-04-30 | Simple Agreement for Future Equity (SAFE) | C/A |
| 2024-11-07 | Wefunder Portal LLC | $50K | $1.24M | 2025-04-30 | Simple Agreement for Future Equity (SAFE) | C |
Financials the company filed
Figures from the C-U filed 2026-07-07, as the company reported them.
| As filed | Most recent fiscal year | Prior fiscal year |
|---|---|---|
| Revenue | $332K | $302K |
| Net income | -$1.75M | -$955K |
| Total assets | $2.59M | $738K |
| Cash and equivalents | $1.80M | |
| Short-term debt | $1.80M | |
| Long-term debt | $8.03M |
Employees at filing: 2.
Revenue went from $302K to $332K (+10%). Net loss was $1.75M, against a loss of $955K the year before. It reported $1.80M in cash and $9.83M in debt. These are the company's own figures from the Form C-U filed 2026-07-07.
Progress updates
2026-07-07, C-U:
The Offering successfully reached its Target Offering Amount on July 6, 2026, having closed on funds totaling $42,352.43.
2026-05-04, C-U:
At the close of the offering, the issuer closed on $470,059.08 and 93,423 number of securities.
2025-11-28, C-U:
The final number is $2,509,425.00 in investments.
People who signed the filing
- Dr. Isaac Eliaz, Director
Every filing
| Filed | What it is | Filing |
|---|---|---|
| 2026-07-07 | Progress update | C-U |
| 2026-06-10 | Offering | C |
| 2026-05-04 | Progress update | C-U |
| 2026-04-29 | Annual report | C-AR |
| 2026-03-03 | Offering amended | C/A |
| 2025-12-08 | Offering | C |
| 2025-11-28 | Progress update | C-U |
| 2025-08-07 | Offering amended | C/A |
| 2025-07-22 | Offering amended | C/A |
| 2025-06-13 | Offering amended | C/A |
| 2025-04-25 | Offering amended | C/A |
| 2025-03-31 | Offering amended | C/A |
| 2025-03-25 | Offering amended | C/A |
| 2024-11-07 | Offering | C |
What to check before investing
- Read the offering page on Dealmaker Securities LLC: it states the valuation or cap and the minimum investment, which the SEC filing does not.
- Compare the terms above with the numbers: what does the price imply against revenue of $332K?
- Look at who signed the filing and what else they have run (the founder Snapshot below).
- Check the deadline and what happens if the target is missed.
- You cannot easily sell a crowdfunding security; invest only what you can leave tied up.
A crowdfunding round is won in public. FoxPlug turns your commits, deploys and releases into the posts and visuals that keep the story moving while the offering is open.
Build your launch kitRun a Snapshot on Dr. Isaac Eliaz: other companies, roles and the record behind them. Order Full Report from there if you need more.
Snapshot the foundersTools for this story
Each opens in a new tab, filled in for Eliaz Therapeutics Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A company raising money from the public under Regulation Crowdfunding has to file with the SEC before the offering opens, and has to raise through a single registered intermediary: a funding portal or a broker-dealer. The first filing, Form C, states how much the company is trying to raise, the most it will accept, the deadline, the security and its price, the intermediary and what the intermediary is paid, and two years of the company's own financial figures.
After that the company files amendments when terms change, progress updates as the raise moves, and an annual report each year until it stops reporting. Every row here is one of those filings, linked to the filing itself, so each figure can be checked at the source. Figures are exactly as the company filed them; where a filing leaves a field blank, so does this page. Nothing here is investment advice, and a filing is the company's own statement, not a verification of it.